UY29248A1 - Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización - Google Patents
Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilizaciónInfo
- Publication number
- UY29248A1 UY29248A1 UY29248A UY29248A UY29248A1 UY 29248 A1 UY29248 A1 UY 29248A1 UY 29248 A UY29248 A UY 29248A UY 29248 A UY29248 A UY 29248A UY 29248 A1 UY29248 A1 UY 29248A1
- Authority
- UY
- Uruguay
- Prior art keywords
- indoles
- compositions
- replaced
- contain
- manufacturing procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere principalmente a la preparación de indoles sustituidos, de las composiciones que los contienen, a su procedimiento de preparación, y a su utilización como medicamento, en particular como agentes anticancerosos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0412966A FR2878849B1 (fr) | 2004-12-06 | 2004-12-06 | Indoles substitues, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29248A1 true UY29248A1 (es) | 2006-06-30 |
Family
ID=34954266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29248A UY29248A1 (es) | 2004-12-06 | 2005-12-06 | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización |
Country Status (14)
Country | Link |
---|---|
US (1) | US7566736B2 (es) |
EP (1) | EP1841762A1 (es) |
CN (1) | CN101098868A (es) |
AR (1) | AR052257A1 (es) |
AU (1) | AU2005313253A1 (es) |
CA (1) | CA2586991A1 (es) |
FR (1) | FR2878849B1 (es) |
GT (1) | GT200500357A (es) |
PA (1) | PA8654701A1 (es) |
SV (1) | SV2006002319A (es) |
TN (1) | TNSN07167A1 (es) |
TW (1) | TW200634007A (es) |
UY (1) | UY29248A1 (es) |
WO (1) | WO2006061493A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2884821B1 (fr) * | 2005-04-26 | 2007-07-06 | Aventis Pharma Sa | Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation |
DE102005037499A1 (de) * | 2005-08-09 | 2007-02-15 | Merck Patent Gmbh | Pyrazolderivate |
EP1981887A2 (en) * | 2006-02-01 | 2008-10-22 | SmithKline Beecham Corporation | Pyrrolo[2,3,b]pyridine derivatives useful as raf kinase inhibitors |
US7838542B2 (en) * | 2006-06-29 | 2010-11-23 | Kinex Pharmaceuticals, Llc | Bicyclic compositions and methods for modulating a kinase cascade |
DK2134685T3 (en) | 2007-04-16 | 2015-12-07 | Abbvie Inc | 7-unsubstituted indole derivatives as MCL-1 inhibitors |
CN102532042A (zh) * | 2010-12-30 | 2012-07-04 | 上海医药工业研究院 | 一种芳基脲类化合物、其中间体及其应用 |
TW201414734A (zh) | 2012-07-10 | 2014-04-16 | Takeda Pharmaceutical | 氮雜吲哚衍生物 |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
GB201310460D0 (en) * | 2013-06-12 | 2013-07-24 | Lytix Biopharma As | Compounds |
US9765018B2 (en) | 2013-07-01 | 2017-09-19 | Bristol-Myers Squibb Company | IDO inhibitors |
UY35945A (es) | 2014-01-09 | 2015-08-31 | Takeda Pharmaceutical | Derivados de azaindol |
KR20210117261A (ko) | 2018-12-31 | 2021-09-28 | 바이오메아 퓨전, 인크. | 메닌-mll 상호작용의 비가역적 억제제 |
WO2020142559A1 (en) | 2018-12-31 | 2020-07-09 | Biomea Fusion, Llc | Inhibitors of menin-mll interaction |
AU2022331496A1 (en) | 2021-08-20 | 2024-02-29 | Biomea Fusion, Inc. | Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6376529B1 (en) * | 1995-06-07 | 2002-04-23 | Peng Cho Tang | Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
BR9609353A (pt) * | 1995-06-07 | 1999-05-11 | Sugen Inc | Composição farmacêutica conveniente para administração em humanos processo para melhorar sintomas de uma desordem proliferativa celular e compostos |
US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
AP2003002929A0 (en) * | 2001-06-23 | 2003-12-31 | Aventis Pharma Inc | Pyrrolopyrimidines as protein kinase inhibitors |
GB0115393D0 (en) | 2001-06-23 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
US7129225B2 (en) * | 2001-10-22 | 2006-10-31 | The Research Foundation Of State University Of New York | Protection against and treatment of hearing loss |
EP1539742B1 (en) * | 2002-06-24 | 2006-11-08 | Schering Corporation | Indole derivatives useful as histamine h3 antagonists |
FR2842526B1 (fr) * | 2002-07-16 | 2007-07-13 | Aventis Pharma Sa | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments |
JP2004149429A (ja) * | 2002-10-29 | 2004-05-27 | Takeda Chem Ind Ltd | インドール化合物およびその用途 |
US7429596B2 (en) | 2003-06-20 | 2008-09-30 | The Regents Of The University Of California | 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof |
GB0500492D0 (en) | 2005-01-11 | 2005-02-16 | Cyclacel Ltd | Compound |
EP2397476A3 (en) | 2005-07-22 | 2011-12-28 | Shionogi & Co., Ltd. | Indole derivative having PGD2 receptor antagonist activity |
-
2004
- 2004-12-06 FR FR0412966A patent/FR2878849B1/fr not_active Expired - Fee Related
-
2005
- 2005-12-02 CA CA002586991A patent/CA2586991A1/fr not_active Abandoned
- 2005-12-02 CN CNA2005800461740A patent/CN101098868A/zh active Pending
- 2005-12-02 WO PCT/FR2005/003003 patent/WO2006061493A1/fr active Application Filing
- 2005-12-02 EP EP05824445A patent/EP1841762A1/fr not_active Withdrawn
- 2005-12-02 AU AU2005313253A patent/AU2005313253A1/en not_active Withdrawn
- 2005-12-05 TW TW094142712A patent/TW200634007A/zh unknown
- 2005-12-05 AR ARP050105076A patent/AR052257A1/es unknown
- 2005-12-06 SV SV2005002319A patent/SV2006002319A/es unknown
- 2005-12-06 PA PA20058654701A patent/PA8654701A1/es unknown
- 2005-12-06 UY UY29248A patent/UY29248A1/es not_active Application Discontinuation
- 2005-12-06 GT GT200500357A patent/GT200500357A/es unknown
-
2007
- 2007-05-04 TN TNP2007000167A patent/TNSN07167A1/fr unknown
- 2007-06-04 US US11/757,613 patent/US7566736B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2005313253A1 (en) | 2006-06-15 |
PA8654701A1 (es) | 2006-07-03 |
TNSN07167A1 (fr) | 2008-11-21 |
US20070259910A1 (en) | 2007-11-08 |
SV2006002319A (es) | 2006-07-07 |
US7566736B2 (en) | 2009-07-28 |
GT200500357A (es) | 2007-01-09 |
FR2878849B1 (fr) | 2008-09-12 |
AR052257A1 (es) | 2007-03-07 |
CA2586991A1 (fr) | 2006-06-15 |
TW200634007A (en) | 2006-10-01 |
EP1841762A1 (fr) | 2007-10-10 |
FR2878849A1 (fr) | 2006-06-09 |
CN101098868A (zh) | 2008-01-02 |
WO2006061493A1 (fr) | 2006-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY29248A1 (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
UY29341A1 (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación | |
ECSP088152A (es) | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
UY29361A1 (es) | Pirroles e imidazoles sustituídos, composiciones que los contienen, procedimiento de fabricación y utilización | |
ECSP088252A (es) | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
CR9463A (es) | Pirrolinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion | |
UY29236A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización. | |
CR10247A (es) | Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica | |
CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
GT200900309A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
DOP2006000015A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricación | |
CR10371A (es) | Compuestos heterociclicos apropiados para tratar trastornos que responden a la moduilacion del receptor de serotonina 5ht6 | |
UY29371A1 (es) | Pirroles sustituídos, composiciones que los contienen, proceso de fabricación y utilización | |
CR9115A (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
ECSP088899A (es) | Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparación, composiciones que las contienen y utilización | |
UY30368A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion | |
DOP2005000246A (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
NI201200103A (es) | NUEVOS DERIVADOS ( HETEROCICLO - TETRAHIDRO - PIRIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y ( HETEROCICLO - DIHIDRO - PIRROLIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75 | |
ECSP088897A (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización | |
UY32154A (es) | Derivados de isoquinolinona, procesos para su preparacion, composiciones farmaceuticas que los contiene y su uso en terapia | |
UY29235A1 (es) | Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparación, composiciones que las contienen y utilización | |
UY29501A1 (es) | Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización | |
GT200500165A (es) | Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20130308 |